Calculating the Costs and Benefits of Advance Preparations for Future Pandemics / Rachel Glennerster, Christopher M. Snyder, Brandon Joel Tan.

By:

Glennerster, Rachel

Contributor(s):

Material type: Text

TextSeries: Working Paper Series (National Bureau of Economic Research) ; no. w30565.Publication details: Cambridge, Mass. National Bureau of Economic Research 2022.Description: 1 online resource: illustrations (black and white)Subject(s):

Other classification:

Online resources:

Available additional physical forms:

Hardcopy version available to institutional subscribers

Abstract: The Covid-19 pandemic is estimated to have caused over 7 million deaths and reduced economic output by over $13 trillion to date. While vaccines were developed and deployed with unprecedented speed, pre-pandemic investments could have accelerated their widespread introduction, saving millions of lives and trillions of dollars. Combining estimates of the frequency and intensity of pandemics with estimates of mortality, economic-output, and human-capital losses from pandemics of varying severities, we calculate expected global losses from pandemics of over $800 billion annually. According to our model, spending $60 billion up front to expand production capacity for vaccines and supply-chain inputs and $5 billion every year thereafter would be sufficient to ensure production capacity to vaccinate 70% of the global population against a new virus within six months, generating an expected net present value (NPV) of over $400 billion. A proportionate advance-investment program undertaken by the United States alone would generate an expected NPV of $47 billion ($141 per capita).

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Status	Date due	Barcode	Item holds
Working Paper	Biblioteca Digital	Colección NBER	nber w30565 (Browse shelf(Opens below))	Not For Loan

Total holds: 0

Collection: Colección NBER Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	nber w30562 ESG Confusion and Stock Returns: Tackling the Problem of Noise /	nber w30563 The Effects of Racial Segregation on Intergenerational Mobility: Evidence from Historical Railroad Placement /	nber w30564 Two-way Fixed Effects and Differences-in-Differences Estimators with Several Treatments /	nber w30565 Calculating the Costs and Benefits of Advance Preparations for Future Pandemics /	nber w30566 Global Universal Basic Skills: Current Deficits and Implications for World Development /	nber w30567 Older Workers' Employment and Social Security Spillovers through the Second Year of the COVID-19 Pandemic /	nber w30568 Long Social Distancing /	Next

October 2022.

The Covid-19 pandemic is estimated to have caused over 7 million deaths and reduced economic output by over $13 trillion to date. While vaccines were developed and deployed with unprecedented speed, pre-pandemic investments could have accelerated their widespread introduction, saving millions of lives and trillions of dollars. Combining estimates of the frequency and intensity of pandemics with estimates of mortality, economic-output, and human-capital losses from pandemics of varying severities, we calculate expected global losses from pandemics of over $800 billion annually. According to our model, spending $60 billion up front to expand production capacity for vaccines and supply-chain inputs and $5 billion every year thereafter would be sufficient to ensure production capacity to vaccinate 70% of the global population against a new virus within six months, generating an expected net present value (NPV) of over $400 billion. A proportionate advance-investment program undertaken by the United States alone would generate an expected NPV of $47 billion ($141 per capita).